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by Edwar4]' CalabreseOver the past several yearsthere has emerged awidespread recognition
that numerous environmental
pollutants, consumer products,
and certain medications may
be carcinogenic. Many people
refer to this continuing recog-
nition of carcinogenic agents
as the carcinogen of the week
club. One day we are told that
peanut butter contains a car-
cinogen, that saccharin causes
cancer, that ham and bacon
contain nitrite which may
form the carcinogen nitrosam-
ine in your stomach, that die-
sel exhaust is very mutagenic,
and that the American Petro-
leum Institute recommends
that self-service gasoline sta-
tions put up a warning similar
to the one that is on sac-
charin-sweetened diet soft
drinks. While this list could
go on and on through hun-
dreds of chemical agents,
it is important to realize that
much of our information indi-
cating that these compounds
are harmful to people comes
not from studies with humans,
but from experiments with
mice and rats. The critical
question then is how relevant
are rodents in predicting how
you and I may respond to
such agents? Is a rat just a
miniature version of a human
or is a human just a big rat?
Let's take a look at this issue.
The vast majority of
cancer studies are in fact car-
ried Out on mice and rats.
This is the standard procedure
used by our National Toxicol-
ogy Program. Scientists typi-
cally figure Out the largest
amount of a chemical that
mice or rats can consume
without getting noticeably ill,
and then feed it to them for
most of their adult lives,
about two years. This high
dose is called the maximum
tOlerable dose or MTD. The
scientists also use a second
dose which is usually one-half
the MTD. 50 male and 50
female animals are tested for
each dose of the chemical, as
well as a group given no
chemical at all, called the con-
trol or comparison group. At
a predetermined time, near
the normal end of their lives,
all of the animals still alive
are sacrificed and examined by
pathologists for various dis-
eases, including cancer. All of
the animals that have died
before this predetermined
time are also examined in the
identical manner.
In order to ensure that no
bias influences the outcome of
the analysis of the study, the
pathologists are given coded
specimens so that they don't
know which treatment group
the specific specimen comes
from. Consequently, the study
is designed to give as fair an
assessment of the study as
possible.
This describes in general
terms how cancer studies are
carried out. The issue still
remains - are these studies
helpful in predicting how hu-
"mans respond to the chemicals
given to the mice and rats?
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Does it make sense to give
the rodents extremely high
doses of a suspected carcino-
gen especially when humans
may be exposed to only a tiny
fraction of what the animals
received;> This is a critical
issue today. Recall all the
commotion over the question
of saccharin's potential carcin-
ogenicity. The controversy
seemed to stem from the fact
that the investigatOrs gave the
rat the saccharin equivalent of
800-1000 cans of diet soda
each day of their lives. Many
in the general public believed
that giving such unrealistic
exposures to the animal could
not be of any relevance to the
human condition in which peo-
ple may drink only a can or
twO each day. It is interesting
to note that the saccharin study
was actually one of the most
"relevant" studies conducted
since many agents are tested
at levels which exceed normal
human exposure by not just a
factor of 1000 times but liter-
ally by greater than a million
times more!! If the public felt
that the saccharin studies did
not make any sense in terms
of predicting human cancer
risk, what must they think
about these other studies? Of
course, the general public isn't
terribly aware of these other
studies. Yet it is on the basis
of these reports that drinking
water standards and concern
about hazardous waste areas
are evaluated. Why does the
National Toxicology Program
use such large doses when
cancer studies are conducted
and why do many coxicolo-
gists both in and out of gov-
ernment believe that using the
MTD is the right way CO gOI
The answer which these
people give is based both on
science and economics. First
the scientific answer. It is
assumed that the magnitude
of the effect of the carcinogen
is directly in proportion CO the
dose. Using this assumption,
no matter how Iowan expo-
sure may be, some percentage
of the population will still be
adversely affected. There is
therefore no threshold or safe
level of exposure. Based on
the assumption of directly
proportional relationship
between dose and effect, it has
been argued that every expo-
sure to a carcinogenic agent,
no matter how small, will
offer some degree of cancer
risk. It is further assumed that
one can predict what will
happen at low doses based on
what happens at grossly
higher doses such as at the
MTD. That, in brief, is the
argument that scientists use
when they say it is legitimate
to extrapolate from high to
low doses of carcinogens.
It has been argued that if
we use a much larger number
of animals, for example 1000
instead of 50 per treatment
group, we could use more
realistic (as in lower) doses,
since the larger number of
animals would permit us to
detect a lower risk - thus the
lower dose. However, since
studies with 50 animals per
group already cost over one
million dollars and since we
never know the actual risk we
are dealing with, it just
doesn't make any sense to
change the current scheme.
So, in effect, what the
researchers do is to use a
small number of rats or mice,
give them the highest dose
they can handle over a life-
time, and then somehow
extrapolate down to a lower,
more realistic dose. Does this
make sense? If not, are there
ways it could be improved?
At the present time, the
best argument supporting the
current testing system IS
financial and nOt scientific.
The assumption that one can
predict cancer risk from the
consumption of one soda per
day based upon responses
observed at grossly higher
levels (for example, 1000 cans
per day) is just that, an
assumption. It is quite possi-
ble that nOthing bad may
happen at low levels of expo-
sure. While the body may nOt
be able to deal effectively with
a massive chemical challenge,
it may work just fine if the
carcinogen is given in minute
Have you taken a walk
through a pet store recently
and stopped to look at the
mice? Do these little furry
creatures, with pointed noses,
whiskers and four legs remind
you of yourself? Believe it or
not, your health and life and
that of your family depends
on the ability of mice and rats
to predict how humans
respond to toxic and carcino-
genic agents. Thousands of
substances are allowed to be
used in foods and other con-
sumer products on the basis
of how they affect mice and
rats. If these animals don't
develop cancer or any Other
horrible diseases, the govern-
ment will usually give its O.K.
and before you know it we are
eating the foods or wearing
the products. What confidence
should you have that your
health and life are being ade-
quately protected by our cur-
rent testing scheme?
Let's take a look at why the
government uses rodents to
predict how we may respond.
The rodents are used nOt
because they are excellent
models to predict human
responses or even because
they are the best models.
They are used because of prac-
tical reasons which include
their cost, resistance to infec-
tious diseases, relatively short
life span, and ability to
develop pollutant-induced dis-
eases. While many scientists
feel that monkeys may be bet-
ter models for humans, they
are nOt used in alternative
studies because of their poor
availability, high cost, and
longer life-span. You need an
animal model that can tell you
relatively quickly if an agent
causes cancer; waiting 10-20
years for the answer is just
too long for society to remain
in suspense, even if the study
has a significantly better
chance of being correct. Even
the 2-3 years of a rodent's life
seems too long given the need
to know whether a substance
is a carcinogen. These practi-
cal considerations are power-
ful arguments in deciding
which animal should be used.
amounts. If this is true, then
the whole premise of the cur-
rent cancer program is
undermined. This, in fact, is
true for a whole new class of
carcinogens which apparently
act on the body without
attacking its DNA. However,
untenable as some of the
assumptions used by toxicolo-
gists doing animal cancer stu-
dies may seem, finding accept-
able alternatives to the cur-
rent problems which are
scientifically defensible while
nOt breaking the bank are few
and far between.
Given that scientific
" . '" ,';'t."" ,.,' approaches seem to be at
li.f.' ".. ~jf. "./ ;~y.;~; ! t' a standstill with regard to
" ,.. >''fl' , i :if/' ,n," '
.. ' " J:" . -:. '. '!',' . '~"'" improving t e current sltua-
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,,. Jf;J.,"'~"',:,<f:-::?~:::pJ~iil.!'l'!'Jr,\,t. for change is, as stated before,
._~.t .' t i~1;,:,t·.;c t'W"'J;" I f!nancial. Why? We have
",.' '.;" rf' '~'{ .>J;' ;~~.J" . lIteral.ly tens ~f thousands of
, J J". ",r" chemICals whICh we desper-
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~.. ]N' pOtential carcinogenicity. If(, .,,\,1 ,.1- ' • each one were to cost over a
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... '/:1)" even considering all of the
,.ct '';' other possible health con-
I·,', ; A cerns, would be astronomical.
.,i ", .' Consequently, there are strong
, -~ .1~:' '" . t . efforts being made to try to
1: shorten or even circumvent
, the lifetime cancer studies
with shorter, less expensive
studies which can reliably
predict whether an agent may
ij be carcinogenic. However, all
, known short-term predictive
tests for carcinogenicity are
Julie Polvinen . h I I' . d' h'10 erent y Imlte 10 t elr
ability to predict the actual
risk of cancer. Often JUSt
knowing that an agent may
cause cancer is nOt enough
information. Our society
needs to know what the risk
or chance of developing
cancer is for each dose level of
a chemical. Thus, we should
try to find a way to incorpo-
rate the enormous benefits of
our technological achieve-
ments while at the same time
nOt falling victim to them.
Now let's investigate how
well rats and mice simulate
the human organism and why
they are presently used in
cancer studies.
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Given the praerical reasons
for why we should use
rodenrs, what about the bio-
logical reasons? That is, can
these animals predier how you
and I will respond I
This is a most difficult
question ro resolve. The
answer, as I see it, is that the
rat can give a fairly decenr
indication of how an agenr
may affect people. In orher
words, like an archer, ofren
times we will hit the rarget
but don't expeer us ro hit the
bull's-eye. Take, for example,
the cases of asbesros, vinyl
chloride and cigarerre smoke.
All three are human carcino-
gens and all three cause
cancer in rodenrs. In conrrast,
arsenic is also a known
human carcinogen. However,
arsenic has been tested over a
dozen times in mice and rats
and has never been found ro
cause cancer. Gerring 3 out of
every 4 right on tests in
school means you pass the
tesr. However, when we are
dealing with potenrial cancer
causing agenrs, even one
wrong out of 1000 is un-
acceptable given the untold
misery the mistake is likely
to cause.
That studies using the rat
should miss one every now
and then is nor unexpeered.
Despite some striking similar-
ities between humans and
rodenrs, there are many dif-
ferences which can easily spell
the difference between devel-
oping cancer or nor. For
example, rodenrs have differ-
enr numbers and rypes of bac-
teria living in their digestive
traers than people; they tend
ro excrete a higher proporrion
of heavier compounds
through the bile; they synrhe-
size ascorbic acid in their liv-
ers; they don't have gall
bladders; they concentrate
their urine much more; and
they always breathe through
their noses, among many
other differences. Given so
many differences, it is often
surprising that they do as
decenr a job as they do!
It is because of the inherenr
limitations of anyone species
ro predict accurately how
humans may respond that the
National Toxicology Program
uses not one but two species -
mice and rats - in their testing
scheme. Presumably, they fig-
ure that if one species doesn't
pick out the adverse health
effect, then maybe a second
one would. Using two species,
in fact, played an imporranr
role in the study sponsored
by the American Petroleum
Institute on the carcin-
ogeniciry of unburned
gasoline. In that case,
only the male rat was
sensitive. If only the
mouse had been used,
then the callCer effect
would have been missed.
This type of redundancy
in the testing system is
thought ro help ensure
that a carcinogen will not
slip through.
The interesting thing
about the currenr testing
programs is that we
really don't know how
successful they are. It is
very hard to later prove
that "compound X"
which caused cancer in
the rats was, or wasn't
carcinogenic in humans.
Human population stud-
ies are generally some-
what insensitive unless
we are dealing with a
very rare type of cancer
(as in the case of vinyl
chloride-induced angio-
sarcoma) or a very potent




one a little of a comment
that Senaror Howard
Baker made about
Reaganomics in the early
1980's. He said that the eco-
nomic course Reagan was
charring for the counrry was'a
"river boat gamble." At least
in the case of Presidenr Rea-
gan's program, one can tell
after a cerrain number of
years if it was the right way ro
go. However, in the case of
cancer testing programs one
may never know.
Finally, it has become
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fashionable in scienrific circles
ro discuss the cancer risks of
various activities. For exam-
ple, drinking a quarr of water
each day with a chloroform
level of 100 parrs per billion,
the level allowed by the EPA,
is thought ro have a risk of
causing four cancers per
10,000 persons over a life-
time. One flight from Bosron
to L.A. and back will increase
one's risk of cancer by one in
a million because of the extra
amounr of cosmic rays you
receive at that high altitude.
Eating 20 peanut butter
sandwiches will also increase
your cancer risk by one in a
million because of the carcin-
ogenic conraminanr called
aflaroxin found in most com-
mercially available brands.
. . . the value of current risk
predictions is not the calculated risk we
are told, because this could be way off
the mark. The real value at present lies
in the ranking of chemical agents and
activities so that regulatory agencies
may identify the most important areas
where action is needed.
Now we read that as little as
a trillionth of a gram of
dioxin in a cubic meter of air
is predicted to produce about
100 additional cases of cancer
for every million people. Just
what are these numbers or
risks based on?
These numbers are really
predictions of what experts
think will happen based on
previous studies, usually with
mice or rats. Only in very
limited situations are these
predictions based on human
studies. As previously dis-
cussed, the typical situation
involves scientists conducting
a study in which the animal
receives a very high dose of a
chemical over its entire life-
time. If the substance causes
cancer in the animal, then
predictions like the ones we
are talking about are made.
The key element here is that
we are trying to predict what
will happen at very low levels
of exposure based on studies
in which grossly higher levels
were used. If the findings of a
study are positive, mathemati-
cians apply certain formulas
to the cancer data. These
mathematical manipulations
allow us to calculate a risk at
any level of exposure one
desires to know. This process
of predicting what will
happen at doses beyond those
used in a study is called
extrapolation. The further the
doses are from those used in
the study the more risky the
endeavor.
But, now for a simple ques-
tion. How can one tell if a
prediction is correct or even
close to being correct? The
sad fact of the matter is that
these cancer risk predictions
can never really be proven or
disproven. Why? Consider the
question: How would you
even prove that a risk exists
for one cancer in a million
people over a 70 year life-
time? To do this you would
need over 70 years to conduct
the study, the size of a budget
that only Fort Knox could
hold, and the luck of a dozen
Irish sweepstakes winners.
The simple fact is that the
risks are calculated without
the intention to try the
impossible - that is, to vali-
date them!
Another important point to
consider in this whole process
is that when these risks for
humans are calculated based
on animal studies, it is
assumed that the human and
rat (or mouse) respond in an
identical way to a carcinogen.
Of course, this could not be
true. Nevertheless, this is an
assumption that is always
made. Nobody knows
whether the rat may be mor~
or less sensitive, nor how
much more or less. All in all,
the process whereby toxicolo-
gists go about predicting
cancer risks is heaped with
uncertainties.
Since the process used to
predict cancer risk is based on
several questionable assump-
tions and cannot be empiri-
cally verified, predicting
cancer risk is problematic.
However, society needs to
begin to get answers to these
questions. To be able to dif-
ferentiate between activities
and products on the basis of
cancer risk is important in
establishing government pol-
icy, developing drinking water
and air quality standards, and
affecting the public's choice of
activities. However, the scien-
tific community and the
general public must realize
that the process of predicting
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cancer risks is a new discipline
in the field of public health.
Although we as a society may
need and, in fact, demand
accurate answers, we should
fully understand the limita-
tions of current approaches.
Consequently, in my opinion,
the value of current risk pre-
dictions is not the calculated
risk we are told, because this
could be way off the mark.
The real value at present lies
in the ranking of chemical
agents and activities so that
regulatory agencies may iden-
tify the most important areas
where action is needed.
What then is the bottom
line here? It is that the toxico-
logical community faces a ser-
ies of extraordinary challenges
as it tries to accurately predict
whether a future drug, food
additive, or pesticide is not
only able to do its intended
job but to do it in a manner
that does not adversely influ-
ence the public's health. Cur-
rent procedures have many
limitations and yet decisions
have to be made. We truly
hope that our testing proce-
dures are up to the task of
protecting the public. But
enough exceptions or failures
exist to preclude overconfi-
dence. We must recognize
that the demands on the toxi-
cologist often exceed the
capacity of this science to
deliver the answers we need.
Yet, progress has been made.
Much more, however, is
needed and it can proceed
with the continued support of
the American public to
demand that quality of our
scientific database and judge-
ments in this field of toxico-
logical risk assessment be
maintained and expanded -
because without such im-
provements the enormous
uncertainties we face can
undercut the basic right
to a safe and healthy
environment. •
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